Pharmaceuticals, Biotechnology and Life Sciences
– Interim results to be presented September 17 at the European Society for Medical Oncology (ESMO) Congress 2021 – –…
New quality of life data for 177Lu-PSMA-617 plus standard of care shows delay in worsening of health-related quality of life…
Objective response rate of 33% and median duration of response not reached with 19.4 months median follow-up in PD-L1+ tumors;…
RESEARCH TRIANGLE PARK, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the United…
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA: 20MP)…
BXCL701 plus KEYTRUDA® (pembrolizumab) demonstrates encouraging anti-tumor activity in heavily pre-treated mCRPC patients with adenocarcinoma BXCL701 combination continues to exhibit…
REDWOOD CITY, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies…
BOSTON, Sept. 15, 2021 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of…
ERYTECH to Host on September 21, 2021 Second Quarter 2021 conference call and Business Update Lyon (France) and Cambridge, MA…
CAMBRIDGE, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) — Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to…